Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Sale
Global Bovine Respiratory Disease Treatment Market Share, Size, Analysis: By Disease Type: Pneumonia (Lower Respiratory Tract Infections), Upper Respiratory Tract Infections, Diphtheria; By Drug Type: Antibiotics, Others; By End Use; Regional Analysis; Market Dynamics; Competitive Landscape: Industry Events and Developments; 2023-2028
Global Bovine Respiratory Disease Treatment Market Outlook
The global bovine respiratory disease treatment market is estimated to develop at a CAGR of 11.5% during 2023-2028. Bovine respiratory disease is a generic term for respiratory disease in cattle triggered by multiple factors, either individually or collectively. Bovine respiratory disease may attack the lower or upper respiratory tract. North America and Europe are likely to be significant markets.
Global Market Likely to be Driven by the Need to Effectively Treat Bovine Respiratory Disease
Bovine respiratory disease is a damaging disease that affects cattle health and leads to high mortality. In fact, the disease is a key cause of death in preweaned calves in USA and is behind almost fifty percent of total feedlot deaths. Bovine respiratory disease touches more animals than all other ailments collectively and costs the industry over $550 million per year. In Europe, bovine respiratory disease is a major source of morbidity and mortality of dairy youngstock and beef cattle.
Bovine respiratory disease may be triggered by pathogens – viral as well as bacterial. Stress contributes to the disease complex. Stress factors include humidity, weather, change in temperature, weaning, change of feed, etc. Clinical symptoms rely on several factors such as animal age, stage of disease and causative organism. Symptoms include fever; depression; reduced appetite; dullness; shallow and rapid breathing; coughing; serous, purulent or bloody eye and nasal release; and salivation.
Many virus and bacteria strains may trigger the disease, making it challenging to treat effectively. Treatment is particularly directed to the illness and the indications. Medication may include anti-infectious agents (Sulfas and Antibiotics), antiparasiticides, non-steroidal anti-inflammatories, mucolytics, bronchodilators, oral rehydration fluids. Several antimicrobial drugs are indicated to treat bovine respiratory disease. Drugs such as florfenicol, tulathromycin, enrofloxacin, and danofloxacin have been reported to display similar effectiveness in treating the condition. However, antimicrobial resistance associated with the use of these drugs is an important consideration.
Nonsteroidal anti-inflammatories (NSAIDs) (combined with an antimicrobial drug) are generally indicated to treat the condition. Such an approach has also been suggested to improve animal growth.
There are Serious Economic Consequences Associated with the Condition
Bovine respiratory disease has serious economic impacts. In the American beef industry, the disease is a leading source of mortality and morbidity in feedlots, leading to loss in performance, health, and quality of carcass. The dairy industry in the US is significantly affected by bovine respiratory disease as the ailment forms a key cause of death in weaned calves; bovine respiratory disease impacts survivability and decreases dairy performance. Economic losses include loss due to death, reduced weight and decreased rate of weight gain, and extra labour and treatment costs.
Developments in Research Expected to Boost Market Growth
Continual research is being carried out in the domain to develop novel solutions. For example, in 2021, it was reported that a pen-side test developed for bovine respiratory disease could help save significant amounts of money for the cattle industry, and decrease antibiotic use. Researchers at Purdue University were successful in developing an on-site bovine respiratory disease test that gave results within one hour. The new technology could identify three (Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni) of the top four bacterial strains that triggered bovine respiratory disease. Such developments are likely to drive the global bovine respiratory disease treatment market.
In 2022, it was reported that a multidisciplinary research team was engaged in developing rapid genomic testing methods to change how feedlots decided about antimicrobial use and enhance antimicrobial stewardship. Researchers and scientists leading Genomic ASSETS (Antimicrobial Stewardship Systems from Evidence-Based Treatment Strategies) for Livestock sought to develop rapid testing technology to determine respiratory pathogens and antimicrobial resistance in calves coming into feedlots to develop group-level, precision antibiotic treatment.
Market Segmentation
By disease type, the market is segmented into:
- Pneumonia (Lower Respiratory Tract Infections)
- Diphtheria
- Upper Respiratory Tract Infections
By drug type, the market is divided into:
- Antibiotics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Vaccines
- Immunomodulators
- Others
By end use, the market is classified into:
- Veterinary Hospitals
- Veterinary Clinics
- Others
By region, the market is divided into:
- Europe
- Asia Pacific
- North America
- Middle East and Africa
- Latin America
Key Industry Players in the Market
The report gives a comprehensive assessment of major players in the global bovine respiratory disease treatment market, evaluating their capacity, and observing newest developments such as mergers and acquisitions, plant turnarounds, and capacity expansions; major players include:
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Incorporated
- Zoetis Services LLC.
- Ceva Santé Animale
- Norbrook Group
- Others
The EMR report offers in-depth insights into the industry by through a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Drug Type |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Bovine Respiratory Disease Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Bovine Respiratory Disease Treatment Historical Market (2018-2022)
8.3 Global Bovine Respiratory Disease Treatment Market Forecast (2023-2028)
8.4 Global Bovine Respiratory Disease Treatment Market by Disease Type
8.4.1 Pneumonia (Lower Respiratory Tract Infections)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Upper Respiratory Tract Infections
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Diphtheria
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.5 Global Bovine Respiratory Disease Treatment Market by Drug Type
8.5.1 Antibiotics
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Vaccines
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Immunomodulators
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Bovine Respiratory Disease Treatment Market by End Use
8.6.1 Veterinary Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Veterinary Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Bovine Respiratory Disease Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Boehringer Ingelheim International GmbH
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Elanco Animal Health Incorporated
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Zoetis Services LLC.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Ceva Santé Animale
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Norbrook Group
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Bovine Respiratory Disease Treatment Market: Key Industry Highlights, 2018 and 2028
2. Global Bovine Respiratory Disease Treatment Historical Market: Breakup by Disease Type (USD Million), 2018-2022
3. Global Bovine Respiratory Disease Treatment Market Forecast: Breakup by Disease Type (USD Million), 2023-2028
4. Global Bovine Respiratory Disease Treatment Historical Market: Breakup by Drug Type (USD Million), 2018-2022
5. Global Bovine Respiratory Disease Treatment Market Forecast: Breakup by Drug Type (USD Million), 2023-2028
6. Global Bovine Respiratory Disease Treatment Historical Market: Breakup by End Use (USD Million), 2018-2022
7. Global Bovine Respiratory Disease Treatment Market Forecast: Breakup by End Use (USD Million), 2023-2028
8. Global Bovine Respiratory Disease Treatment Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Bovine Respiratory Disease Treatment Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Bovine Respiratory Disease Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Bovine Respiratory Disease Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Bovine Respiratory Disease Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Bovine Respiratory Disease Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Bovine Respiratory Disease Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Bovine Respiratory Disease Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Bovine Respiratory Disease Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Bovine Respiratory Disease Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Bovine Respiratory Disease Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Bovine Respiratory Disease Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Bovine Respiratory Disease Treatment Market Structure.
Key Questions Answered in the Report
The global market is estimated to grow at a CAGR of 11.5% between 2023 and 2028.
The major market drivers are technological advancements and the growing rising demand for animal meat.
The key market trends include Increasing investments in research and development activities in the medical field, coupled with the rising development of innovative treatment measures for bovine respiratory disease.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The various disease types of bovine respiratory disease treatment in the market include pneumonia (Lower Respiratory Tract Infections), diphtheria, and upper respiratory tract infections.
The various drug types of bovine respiratory disease treatment in the market include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), vaccines, and immunomodulators, among others.
The various end-uses of bovine respiratory disease treatment in the market include veterinary hospitals and veterinary clinics, among others.
The major players in the market are Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Zoetis Services LLC., Ceva Santé Animale, and Norbrook Group, among others.
Treatment of bovine respiratory disease incorporates the suggestion to utilise third generation cephalosporins, fluoroquinolones, florfenicol (a relative of chloramphenicol), or tilmicosin, a macrolide antibiotic.
Symptoms of the bovine respiratory disease include fever of over 40°C, difficulty breathing, nasal discharge, varying degrees of depression, rapid or shallow breathing, diminished or no appetite and coughing.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER